Literature DB >> 15948728

Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.

Masashige Kinoshita1, Toshimasa Nakagawa, Akira Shimizu, Yoji Katsuoka.   

Abstract

BACKGROUND: The coregulators of androgen receptors (AR) influence the transcriptional activity of AR. In order to better understand the mechanism of carcinogenesis in the prostate, we investigated the relationship between AR and AR coregulators in the early stage of prostate cancer.
METHODS: mRNA was purified from 15 samples of prostate cancer and normal tissue and transcribed into cDNA. We screened eight AR coregulators for different gene expressions in prostate cancer, comparing these with normal tissue by a real-time polymerase chain reaction Syber green method, then quantified each component of the AR transcriptional complex by a real-time PCR hybri-probe method. The extent of gene expression similarity was compared by simple Pearson correlation coefficient analysis between prostate cancer and normal tissue. We applied a z-test to calculate significant differences between r-values.
RESULTS: We found that the gene expression level of FHL2 decreased in prostate cancer compared with that of normal tissue and the gene expressions of PSA, AR and SMRT were not significant. The correlation coefficient analysis revealed that strong associations were found in the pairs of AR versus SMRT, AR versus FHL2 and SMRT versus FHL2 in prostate cancer, whereas similarity was found only in the pair of AR versus FHL2 in normal tissue. No association was observed between prostate-specific antigen and other genes.
CONCLUSION: These results demonstrate that the AR-AR coregulator relationship is different between prostate cancer and normal tissue, leading to the hypothesis that the AR transcriptional complex is regulated differently between prostate cancer and normal tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948728     DOI: 10.1111/j.1442-2042.2005.01093.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  10 in total

1.  Oncogene functions of FHL2 are independent from NF-kappaBIalpha in gastrointestinal cancer.

Authors:  Liang Qiao; Yan Wang; Roberta Pang; Jide Wang; Yun Dai; Juan Ma; Qing Gu; Zesong Li; Yusheng Zhang; Bing Zou; H Y Lan; Benjamin C Y Wong
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

Review 2.  The FHL2 regulation in the transcriptional circuitry of human cancers.

Authors:  Cyanne Ye Cao; Simon Wing-Fai Mok; Vincent Wing-Sang Cheng; Stephen Kwok-Wing Tsui
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

3.  Mammalian Actin-binding Protein-1/Hip-55 Interacts with FHL2 and Negatively Regulates Cell Invasion.

Authors:  Lindsy R Boateng; David Bennin; Sofia De Oliveira; Anna Huttenlocher
Journal:  J Biol Chem       Date:  2016-04-26       Impact factor: 5.157

4.  Reference gene for primary culture of prostate cancer cells.

Authors:  Aline Francielle Damo Souza; Ilma Simoni Brum; Brasil Silva Neto; Milton Berger; Gisele Branchini
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

5.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

6.  Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.

Authors:  Lide Alaña; Marta Sesé; Verónica Cánovas; Yolanda Punyal; Yolanda Fernández; Ibane Abasolo; Inés de Torres; Cristina Ruiz; Lluís Espinosa; Anna Bigas; Santiago Ramón Y Cajal; Pedro L Fernández; Florenci Serras; Montserrat Corominas; Timothy M Thomson; Rosanna Paciucci
Journal:  Mol Cancer       Date:  2014-03-31       Impact factor: 27.401

7.  FHL2 interacts with iASPP and impacts the biological functions of leukemia cells.

Authors:  Wenting Lu; Tengteng Yu; Shuang Liu; Saisai Li; Shouyun Li; Jia Liu; Yingxi Xu; Haiyan Xing; Zheng Tian; Kejing Tang; Qing Rao; Jianxiang Wang; Min Wang
Journal:  Oncotarget       Date:  2017-06-20

8.  Targeting FHL2-E-cadherin axis by miR-340-5p attenuates colon cancer cell migration and invasion.

Authors:  Anwar Algaber; Raed Madhi; Avin Hawez; Carl-Fredrik Rönnow; Milladur Rahman
Journal:  Oncol Lett       Date:  2021-07-03       Impact factor: 2.967

9.  FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.

Authors:  Julia Brun; François-Xavier Dieudonné; Caroline Marty; Judith Müller; Roland Schüle; Ana Patiño-García; Fernando Lecanda; Olivia Fromigué; Pierre J Marie
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

10.  FHL2 regulates hematopoietic stem cell functions under stress conditions.

Authors:  Y Hou; X Wang; L Li; R Fan; J Chen; T Zhu; W Li; Y Jiang; N Mittal; W Wu; D Peace; Z Qian
Journal:  Leukemia       Date:  2014-09-02       Impact factor: 11.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.